31
Participants
Start Date
May 24, 2022
Primary Completion Date
January 26, 2024
Study Completion Date
January 26, 2024
Ustekinumab
This study does not provide dosing instructions for ustekinumab but will engage participants who have been treated with ustekinumab by their corresponding HCPs independent of this study.
Columbia University Medical Center, New York
Medical University of South Carolina, Charleston
Akron Children s Hospital, Akron
Cincinnati Children's Hospital Medical Center, Cincinnati
Michigan Dermatology Institute, Waterford
Dell Children's Medical Center of Central Texas, Austin
Pediatric Rheumatology Consultants of Austin, Austin
Childrens Hospital Los Angeles, Los Angeles
Newport Huntington Medical Group, Huntington Beach
Northwestern University Feinberg School of Medicine Ann & Robert H Lurie Children's Hospital, Chicago
Janssen Research & Development, LLC
INDUSTRY